Abstract
Recurrent respiratory papillomatosis (RRP) is a viral induced disease, associated with exophytic epithelial lesions affecting the upper airways. Problem of treatment is the high recurrence of papilloma growth after surgical removal; therefore adjuvant therapy schemes have been established. Cidofovir was one of the agents used off-label in adjuvant therapy in the last years. However, there is ongoing discussion about the effectiveness and possible side effects. Aim of our study was to share our experience in treatment of RRP with cidofovir during the last 11 years. We analyzed all the data of patients treated for RRP at the Department for Phoniatrics of the Medical University of Graz between 1999 and 2011. 25 out of the 34 treated patients are at the moment under complete remission, in six patients partial remission could be achieved and two patients showed poor response to therapy, therefore the treatment with cidofovir was stopped. 21 patients received one cycle of monthly cidofovir, 11 patients received two and one patient three cycles of therapy. Number of procedures reached from one to six during each cycle. Average cumulative dose of one cycle was 79.7 mg (15–277.5 mg), in one patient 435 mg were used. One patient developed temporary, borderline neutropenia without symptoms. Despite the retrospective approach of this study with the limitation of several incomplete records, our results show promising long-term effects of adjuvant use of cidofovir. During this period, we did not observe any relevant side effects.
Similar content being viewed by others
References
Snoeck R, Wellens W, Desloovere C, Van Ranst M, Naesens L, De Clercq E, Feenstra L (1998) Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine]. J Med Virol 54:219–225
Derkay CS, Darrow DH (2006) Recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol 115:1–11
Derkay CS, Wiatrak B (2008) Recurrent respiratory papillomatosis: a review. Laryngoscope 118:1236–1247
Cundy KC (1999) Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir. Clin Pharmacokinet 36:127–143
Gillen D (2011) Direct healthcare professional communication regarding serious adverse reactions following off-label use of vistide. http://www.cbg-meb.nl/NR/rdonlyres/FFB51936-EC22-4180-A213-9E907F06A774/0/VistideDHPCletterJanuary2011.pdf. Accessed 01 Dec 2011
Dikkers FG (2006) Treatment of recurrent respiratory papillomatosis with microsurgery in combination with intralesional cidofovir—a prospective study. Eur Arch Otorhinolaryngol 263:440–443
Bernard HU, Burk RD, Chen Z, van Doorslaer K, Hausen H, de Villiers EM (2010) Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 401:70–79
Mounts P, Kashima H (1984) Association of human papillomavirus subtype and clinical course in respiratory papillomatosis. Laryngoscope 94:28–33
Goon P, Sonnex C, Jani P, Stanley M, Sudhoff H (2008) Recurrent respiratory papillomatosis: an overview of current thinking and treatment. Eur Arch Otorhinolaryngol 265:147–151
Stamataki S, Nikolopoulos TP, Korres S, Felekis D, Tzangaroulakis A, Ferekidis E (2007) Juvenile recurrent respiratory papillomatosis: still a mystery disease with difficult management. Head Neck 29:155–162
Schraff S, Derkay CS, Burke B, Lawson L (2004) American Society of Pediatric Otolaryngology members’ experience with recurrent respiratory papillomatosis and the use of adjuvant therapy. Arch Otolaryngol Head Neck Surg 130:1039–1042
Huber K, Sadick H, Gotte K (2005) Current therapeutic options for recurrent respiratory papillomatosis. HNO 53:921–927
Lalezari JP, Stagg RJ, Kuppermann BD, Holland GN, Kramer F, Ives DV, Youle M, Robinson MR, Drew WL, Jaffe HS (1997) Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial. Ann Intern Med 126:257–263
Armbruster C (2002) Novel treatments for recurrent respiratory papillomatosis. Expert Opin Investig Drugs 11:1139–1148
Tanna N, Sidell D, Joshi AS, Bielamowicz SA (2008) Adult intralesional cidofovir therapy for laryngeal papilloma: a 10-year perspective. Arch Otolaryngol Head Neck Surg 134:497–500
Wierzbicka M, Jackowska J, Bartochowska A, Jozefiak A, Szyfter W, Kedzia W (2011) Effectiveness of cidofovir intralesional treatment in recurrent respiratory papillomatosis. Eur Arch Otorhinolaryngol 268:1305–1311
McMurray JS, Connor N, Ford CN (2008) Cidofovir efficacy in recurrent respiratory papillomatosis: a randomized, double-blind, placebo-controlled study. Ann Otol Rhinol Laryngol 117:477–483
Tjon Pian Gi RE, Dietz A, Djukic V, Eckel HE, Friedrich G, Golusinski W, Hantzakos A, Lawson G, Remacle M, Rihkanen H, Dikkers FG (2012) Treatment of recurrent respiratory papillomatosis and adverse reactions following off-label use of cidofovir (Vistide®). Eur Arch Otorhinolaryngol 269:361–362
Chung BJ, Akst LM, Koltai PJ (2006) 3.5-Year follow-up of intralesional cidofovir protocol for pediatric recurrent respiratory papillomatosis. Int J Pediatr Otorhinolaryngol 70:1911–1917
Co J, Woo P (2004) Serial office-based intralesional injection of cidofovir in adult-onset recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol 113:859–862
Chhetri DK, Blumin JH, Shapiro NL, Berke GS (2002) Office-based treatment of laryngeal papillomatosis with percutaneous injection of cidofovir. Otolaryngol Head Neck Surg 126:642–648
Broekema FI, Dikkers FG (2008) Side-effects of cidofovir in the treatment of recurrent respiratory papillomatosis. Eur Arch Otorhinolaryngol 265:871–879
Chadha NK, James AL (2007) Antiviral agents for the treatment of recurrent respiratory papillomatosis: a systematic review of the English-language literature. Otolaryngol Head Neck Surg 136:863–869
Conflict of interest
The authors declare no conflict of interest concerning funding sources, relevant patents, financial and business relationship to sponsors, companies related to the research, or the outcome of the studies in the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Graupp, M., Gugatschka, M., Kiesler, K. et al. Experience of 11 years use of cidofovir in recurrent respiratory papillomatosis. Eur Arch Otorhinolaryngol 270, 641–646 (2013). https://doi.org/10.1007/s00405-012-2221-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-012-2221-2